HQY Earnings Date & History
Healthequity Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 5:03 PM ET
Healthequity Inc
Health Care
- Next earnings date
- Thursday, August 27, 2026
- Reporting session
- Time TBD
- EPS estimate
- $1.20
- Revenue estimate
- $352.7M
HQY earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Thursday, May 28, 2026 | Q1 2027 | $1.13 | $1.24 | +10.1% | $354.6M |
| Tuesday, March 17, 2026 | Q4 2026 | $0.91 | $0.95 | +4.5% | $334.6M |
| Wednesday, December 3, 2025 | Q3 2026 | $0.94 | $1.01 | +7.7% | $322.2M |
| Tuesday, September 2, 2025 | Q2 2026 | $0.93 | $1.08 | +16.2% | $325.8M |
What the market is watching in HQY's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next HQY earnings date?
- Healthequity Inc is scheduled to report on Thursday, August 27, 2026 (Time TBD). Dates can change until the company confirms them.
- Does HQY report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for HQY?
- Consensus EPS for the upcoming quarter is $1.20, on revenue of $352.7M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
HQY earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.